Chittajallu Lakshmi Venkata Sharmista, Kaku Rohini, Kondadasula Poshitha, Lim Jun Yi, Zhumabekova Altynai
Department of Obstetrics and Gynecology, Command Hospital (Central Command), Lucknow, IND.
Department of General Medicine, I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, KGZ.
Cureus. 2025 Jan 9;17(1):e77176. doi: 10.7759/cureus.77176. eCollection 2025 Jan.
Maternal immunization is a safe and effective strategy for protecting mothers and infants from vaccine-preventable diseases. This systematic review evaluated the safety and efficacy of various vaccines administered during pregnancy, focusing on maternal and infant outcomes. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science to identify relevant studies. The search used terms and combinations such as ("maternal vaccination" OR "vaccination during pregnancy") AND ("safety" OR "efficacy" OR "immunogenicity") AND ("influenza" OR "DTaP" OR "respiratory syncytial virus" OR "group B streptococcus" OR "COVID-19"). Boolean operators "AND" and "OR" enhanced precision and filtered the limited results to studies published from 2018 to 2024. Eight studies were included in the review after applying inclusion and exclusion criteria. Influenza, diphtheria-tetanus-pertussis, respiratory syncytial virus, group B streptococcus, and COVID-19 vaccines are safe and effective when administered during pregnancy. These vaccines elicit robust immune responses in pregnant women, with efficient transplacental antibody transfer providing passive immunity to newborns. Adverse effects were mostly mild to moderate and similar to those observed in nonpregnant individuals. No significant increase in adverse pregnancy or neonatal outcomes was associated with maternal vaccination. Most of the included randomized controlled trials (had a low risk of bias, thus supporting the reliability of the findings. However, vaccine hesitancy remains a challenge, highlighting the need for transparent communication between healthcare providers and pregnant women. Future research should focus on long-term infant health outcomes, vaccine safety, immunogenicity in diverse populations, and strategies to optimize maternal immunization timing and enhance neonatal antibody persistence. This review supports the implementation of routine maternal vaccination programs and emphasizes the importance of addressing knowledge gaps and ensuring equitable access to immunization during pregnancy.
孕产妇免疫接种是保护母亲和婴儿免受疫苗可预防疾病侵害的一种安全有效的策略。本系统评价评估了孕期接种的各种疫苗的安全性和有效性,重点关注母婴结局。在PubMed、Scopus和Web of Science中进行了全面的文献检索,以确定相关研究。检索使用了诸如(“孕产妇疫苗接种”或“孕期疫苗接种”)与(“安全性”或“有效性”或“免疫原性”)与(“流感”或“白喉-破伤风-百日咳疫苗”或“呼吸道合胞病毒”或“B族链球菌”或“新冠病毒”)等术语和组合。布尔运算符“与”和“或”提高了检索精度,并将有限的结果筛选为2018年至2024年发表的研究。在应用纳入和排除标准后,八项研究被纳入该评价。流感疫苗、白喉-破伤风-百日咳疫苗、呼吸道合胞病毒疫苗、B族链球菌疫苗和新冠病毒疫苗在孕期接种时是安全有效的。这些疫苗在孕妇中引发强烈的免疫反应,有效的经胎盘抗体转移为新生儿提供被动免疫。不良反应大多为轻至中度,与非孕妇人群中观察到的不良反应相似。孕产妇接种疫苗与不良妊娠或新生儿结局的显著增加无关。大多数纳入的随机对照试验偏倚风险较低,因此支持研究结果的可靠性。然而,疫苗犹豫仍然是一个挑战,这凸显了医疗保健提供者与孕妇之间进行透明沟通的必要性。未来的研究应关注婴儿长期健康结局、疫苗安全性、不同人群中的免疫原性,以及优化孕产妇免疫接种时间和增强新生儿抗体持久性的策略。本评价支持实施常规的孕产妇疫苗接种计划,并强调解决知识差距以及确保孕期公平获得免疫接种的重要性。